GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ANG Lifesciences India Ltd (BOM:540694) » Definitions » Days Sales Outstanding

ANG Lifesciences India (BOM:540694) Days Sales Outstanding : 376.71 (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is ANG Lifesciences India Days Sales Outstanding?

ANG Lifesciences India's average Accounts Receivable for the three months ended in Dec. 2023 was ₹766 Mil. ANG Lifesciences India's Revenue for the three months ended in Dec. 2023 was ₹185 Mil. Hence, ANG Lifesciences India's Days Sales Outstanding for the three months ended in Dec. 2023 was 376.71.

The historical rank and industry rank for ANG Lifesciences India's Days Sales Outstanding or its related term are showing as below:

BOM:540694' s Days Sales Outstanding Range Over the Past 10 Years
Min: 62.4   Med: 111.98   Max: 214.66
Current: 214.66

During the past 11 years, ANG Lifesciences India's highest Days Sales Outstanding was 214.66. The lowest was 62.40. And the median was 111.98.

BOM:540694's Days Sales Outstanding is ranked worse than
94.77% of 995 companies
in the Drug Manufacturers industry
Industry Median: 71.56 vs BOM:540694: 214.66

ANG Lifesciences India's Days Sales Outstanding increased from Dec. 2022 (195.81) to Dec. 2023 (376.71).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.


ANG Lifesciences India Days Sales Outstanding Historical Data

The historical data trend for ANG Lifesciences India's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ANG Lifesciences India Days Sales Outstanding Chart

ANG Lifesciences India Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 110.85 126.42 124.28 82.87 153.79

ANG Lifesciences India Quarterly Data
Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 195.81 192.94 134.38 210.04 376.71

Competitive Comparison of ANG Lifesciences India's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, ANG Lifesciences India's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ANG Lifesciences India's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ANG Lifesciences India's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where ANG Lifesciences India's Days Sales Outstanding falls into.



ANG Lifesciences India Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

ANG Lifesciences India's Days Sales Outstanding for the fiscal year that ended in Mar. 2023 is calculated as

Days Sales Outstanding (A: Mar. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Mar. 2022 ) + Accounts Receivable (A: Mar. 2023 )) / count ) / Revenue (A: Mar. 2023 )*Days in Period
=( (1020.55 + 831.482) / 2 ) / 2197.783*365
=926.016 / 2197.783*365
=153.79

ANG Lifesciences India's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (765.622 + 0) / 1 ) / 185.455*365 / 4
=765.622 / 185.455*365 / 4
=376.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ANG Lifesciences India  (BOM:540694) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


ANG Lifesciences India Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of ANG Lifesciences India's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


ANG Lifesciences India (BOM:540694) Business Description

Traded in Other Exchanges
N/A
Address
Ranjit Avenue, B-Block, Darbara Complex, SCO 113, First Floor, District Shopping Complex, Amritsar, PB, IND, 143001
ANG Lifesciences India Ltd is an India-based engaged in the manufacturing of finished pharmaceutical formulations in the form of dry powder for injections. Geographically, the company carries out sales within India, as well as outside India; generating the majority of revenue from the sales of injections within India.

ANG Lifesciences India (BOM:540694) Headlines

No Headlines